share_log

Unity Biotechnology Q4 2023 GAAP EPS $(0.28) May Not Be Comparable To $(0.77) Estimate

Moomoo 24/7 ·  Apr 15 07:22

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.77) by 63.64 percent. This is a 46.15 percent increase over losses of $(0.52) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment